Next, on the basis of our previous observation that the upregulation of CSC marker CD133 contributes to liver tumor initiation [16], we investigated whether the expression of CD133 is also affected by CDCA8 silencing in the CD133+ HCC cell population. The gene discussed is PROM1; the disease is hepatocellular carcinoma.